Vijaya Diagnostic Centre Limited (VIJAYA) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.160x

Based on the latest financial reports, Vijaya Diagnostic Centre Limited (VIJAYA) has a cash flow conversion efficiency ratio of 0.160x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs1.39 Billion ≈ $14.99 Million USD) by net assets (Rs8.65 Billion ≈ $93.55 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Vijaya Diagnostic Centre Limited (VIJAYA) total market value for the company's overall valuation and market capitalisation.

Vijaya Diagnostic Centre Limited - Cash Flow Conversion Efficiency Trend (2019–2026)

This chart illustrates how Vijaya Diagnostic Centre Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Vijaya Diagnostic Centre Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Vijaya Diagnostic Centre Limited ranked by their cash flow conversion efficiency. Explore how high is Vijaya Diagnostic Centre Limited's earnings quality to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Vivendi SA PA:VIV	-0.007x
Sichuan Anning Iron and Titanium Co SHE:002978	-0.068x
Guangzhou SiE Consulting Co Ltd SHE:300687	0.006x
Carabao Group Public Company Limited BK:CBG	0.036x
Century Plyboards (India) Limited NSE:CENTURYPLY	0.116x
H2O America NASDAQ:HTO	0.051x
Tri Continental Closed Fund NYSE:TY	-0.167x
Taihai Manoir Nuclear Equipment Co Ltd SHE:002366	-0.016x

Annual Cash Flow Conversion Efficiency for Vijaya Diagnostic Centre Limited (2019–2026)

The table below shows the annual cash flow conversion efficiency of Vijaya Diagnostic Centre Limited from 2019 to 2026. View today's stock price for Vijaya Diagnostic Centre Limited for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2026-03-31	Rs9.57 Billion ≈ $103.51 Million	Rs2.71 Billion ≈ $29.26 Million	0.283x	+0.65%
2025-03-31	Rs7.99 Billion ≈ $86.42 Million	Rs2.24 Billion ≈ $24.28 Million	0.281x	+1.13%
2024-03-31	Rs6.60 Billion ≈ $71.37 Million	Rs1.83 Billion ≈ $19.82 Million	0.278x	-7.76%
2023-03-31	Rs5.47 Billion ≈ $59.12 Million	Rs1.65 Billion ≈ $17.80 Million	0.301x	-10.51%
2022-03-31	Rs4.70 Billion ≈ $50.78 Million	Rs1.58 Billion ≈ $17.09 Million	0.336x	-6.76%
2021-03-31	Rs3.59 Billion ≈ $38.85 Million	Rs1.30 Billion ≈ $14.02 Million	0.361x	-6.76%
2020-03-31	Rs2.74 Billion ≈ $29.65 Million	Rs1.06 Billion ≈ $11.48 Million	0.387x	-11.49%
2019-03-31	Rs2.07 Billion ≈ $22.39 Million	Rs905.27 Million ≈ $9.79 Million	0.437x	--

About Vijaya Diagnostic Centre Limited

NSE:VIJAYA India Diagnostics & Research

Market Cap

$1.74 Billion

Rs160.56 Billion INR

Market Cap Rank

#6714 Global

#314 in India

Share Price

Rs1558.90

Change (1 day)

+3.51%

52-Week Range

Rs861.40 - Rs1558.90

All Time High

Rs1558.90